Correlation Between Daihan Pharmaceutical and HLB Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Daihan Pharmaceutical and HLB Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Daihan Pharmaceutical and HLB Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Daihan Pharmaceutical CoLtd and HLB Pharmaceutical Co, you can compare the effects of market volatilities on Daihan Pharmaceutical and HLB Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Daihan Pharmaceutical with a short position of HLB Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Daihan Pharmaceutical and HLB Pharmaceutical.

Diversification Opportunities for Daihan Pharmaceutical and HLB Pharmaceutical

0.1

Correlation Coefficient

Daihan Pharmaceutical  HLB Pharmaceutical

Average diversification

The 3 months correlation between Daihan and HLB is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Daihan Pharmaceutical CoLtd and HLB Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLB Pharmaceutical and Daihan Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Daihan Pharmaceutical CoLtd are associated (or correlated) with HLB Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLB Pharmaceutical has no effect on the direction of Daihan Pharmaceutical i.e., Daihan Pharmaceutical and HLB Pharmaceutical go up and down completely randomly.

Pair Corralation between Daihan Pharmaceutical and HLB Pharmaceutical

Assuming the 90 days trading horizon Daihan Pharmaceutical CoLtd is expected to under-perform the HLB Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Daihan Pharmaceutical CoLtd is 3.2 times less risky than HLB Pharmaceutical. The stock trades about -0.05 of its potential returns per unit of risk. The HLB Pharmaceutical Co is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  2,225,000  in HLB Pharmaceutical Co on November 29, 2024 and sell it today you would earn a total of  465,000  from holding HLB Pharmaceutical Co or generate 20.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.28%
Values	Daily Returns

Daihan Pharmaceutical CoLtd  vs.  HLB Pharmaceutical Co

Daihan Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Daihan Pharmaceutical CoLtd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Daihan Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

HLB Pharmaceutical

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in HLB Pharmaceutical Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HLB Pharmaceutical sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Daihan Pharmaceutical and HLB Pharmaceutical

The main advantage of trading using opposite Daihan Pharmaceutical and HLB Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Daihan Pharmaceutical position performs unexpectedly, HLB Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLB Pharmaceutical will offset losses from the drop in HLB Pharmaceutical's long position.

The idea behind Daihan Pharmaceutical CoLtd and HLB Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.